WI Harper is a pioneer in true cross-border venture investing with offices in San Francisco, Beijing, and Taipei. For two decades, we have backed visionary entrepreneurs and helped build revolutionary companies in both US and Greater China. Since inception, we have made over 300 investments and seen in excess of 80 successful liquidity events. We look for promising early-stage technology and healthcare companies where we can add value. Our long-term exposure, experience, and strategic relationships in US and Greater China, uniquely positions us to best assist entrepreneurs in expanding across the two markets.
We invest in inspirational founders with big ideas, whose dreams we can help realize. We have backed both proven entrepreneurs and young visionary upstarts. Historically, we have worked successfully with 1st movers and those with disruptive approaches. And we prefer capital efficient, lean approaches to high growth in large markets.
We do not limit ourselves in terms of investment area, so long as an opportunity fits with our partnership and value-add model. Our current sectors of focus however, are illustrated as follows:
For decades, WI Harper has been a leading investor in a broad range of world-changing technologies including the internet and wireless communications, digital media, electronics, technology-enabled services, and semiconductors. As the pervasiveness of software and mobile devices have become dominant waves, tremendous new opportunities lie in bridging the US and Chinese markets, and in partnering with Chinese tech giants. Some trends we are investing in include: mobile-first technologies and application, expansion of cloud-enabled services and applications, big data and analytics applications, and the Internet of Things – bridging hardware with software solutions.
Healthcare is an enormous market opportunity, in need of disruption. Recent developments in both the US and Chinese markets have shifted the landscape – broader insurance coverage, changing socioeconomics and demographics, widespread mobile internet, globalization of manufacturing and innovation, and advances in biomedical research. These trends are enabling new approaches to the healthcare industry, and we are currently focused on: large-impact healthcare services including both clinical and mobile / digital health, and innovative medical devices and diagnostics, with less emphasis on therapeutic discovery and development.
The WI Harper Advantage
As one of the world’s cross-border venture capital firms, WI Harper has developed a unique approach to helping early-stage companies achieve success on both sides of the Pacific, in the US and Greater China. Some of our competitive advantages include:
Our offices in San Francisco, Beijing, and Taipei work together as a seamless team to identify and capitalize on cross-border investments and technology arbitrage opportunities. This approach provides us with access to the entire emerging market opportunity in Greater China – not just with domestic Chinese companies.
WI Harper has spent decades fostering deep relationships with state and local government leaders while adding value to Greater China (such as playing an integral role in helping to create China’s 3G TDS-CDMA standard). The firm also has extensive ties to the technology industry with advisors from notable market leaders in both the US and Greater China. These partnerships offer unique investment, growth, and liquidity options for our portfolio companies.
Our investment professionals take a “lean forward” approach in partnering with the entrepreneurs we back. We assist our portfolio companies in unlocking access to unique opportunities between the US and Greater China while helping tackle the challenges that can crop up along the way. Our approach improves the odds of success, and has resulted in WI Harper having one of the industry's lowest portfolio loss ratios.